Natasha Petry

1.2k total citations
42 papers, 437 citations indexed

About

Natasha Petry is a scholar working on Pharmacology, Genetics and Geriatrics and Gerontology. According to data from OpenAlex, Natasha Petry has authored 42 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 10 papers in Genetics and 9 papers in Geriatrics and Gerontology. Recurrent topics in Natasha Petry's work include Pharmacogenetics and Drug Metabolism (21 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Practices and Patient Outcomes (9 papers). Natasha Petry is often cited by papers focused on Pharmacogenetics and Drug Metabolism (21 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Practices and Patient Outcomes (9 papers). Natasha Petry collaborates with scholars based in United States, Australia and Canada. Natasha Petry's co-authors include James M. Hoffman, Cyrine E. Haidar, Catherine Hajek, David F. Kisor, Roseann S. Gammal, Yee Ming Lee, Amy Werremeyer, Annette K. Taylor, Sara L. Van Driest and Larisa H. Cavallari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Pharmacology & Therapeutics and Frontiers in Pharmacology.

In The Last Decade

Natasha Petry

37 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natasha Petry United States 11 202 111 98 78 65 42 437
Jivan Moaddeb United States 14 277 1.4× 174 1.6× 86 0.9× 67 0.9× 51 0.8× 21 461
Carolyn R. Rohrer Vitek United States 12 267 1.3× 158 1.4× 109 1.1× 85 1.1× 33 0.5× 17 398
Gillian C. Bell United States 13 398 2.0× 249 2.2× 120 1.2× 96 1.2× 20 0.3× 23 735
Sieta T. de Vries Netherlands 13 59 0.3× 144 1.3× 18 0.2× 123 1.6× 68 1.0× 45 672
Kenneth D. Levy United States 7 138 0.7× 107 1.0× 116 1.2× 89 1.1× 33 0.5× 13 301
Shanna K. O’Connor United States 9 134 0.7× 109 1.0× 28 0.3× 87 1.1× 72 1.1× 34 514
Diego Chaves‐Gnecco United States 10 144 0.7× 65 0.6× 15 0.2× 56 0.7× 63 1.0× 19 472
Pipasha Biswas United Kingdom 10 44 0.2× 89 0.8× 26 0.3× 73 0.9× 10 0.2× 15 528
Catherine Chanfreau‐Coffinier United States 8 94 0.5× 65 0.6× 44 0.4× 46 0.6× 56 0.9× 31 256
Sarah Morris United States 7 82 0.4× 67 0.6× 31 0.3× 27 0.3× 36 0.6× 18 229

Countries citing papers authored by Natasha Petry

Since Specialization
Citations

This map shows the geographic impact of Natasha Petry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha Petry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha Petry more than expected).

Fields of papers citing papers by Natasha Petry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natasha Petry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha Petry. The network helps show where Natasha Petry may publish in the future.

Co-authorship network of co-authors of Natasha Petry

This figure shows the co-authorship network connecting the top 25 collaborators of Natasha Petry. A scholar is included among the top collaborators of Natasha Petry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasha Petry. Natasha Petry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petry, Natasha, et al.. (2025). Impact of a pharmacogenomics (PGx) clinic on patient satisfaction and PGx literacy. Pharmacogenomics. 26(1-2). 23–29.
2.
Sperber, Nina, Megan C. Roberts, Deborah Cragun, et al.. (2024). Pharmacogenetic testing in primary care could bolster depression treatment: A value proposition. Clinical and Translational Science. 17(6). e13837–e13837. 1 indexed citations
3.
Strand, Mark, et al.. (2024). A faculty development series on race and ethnicity in pharmacy education. Currents in Pharmacy Teaching and Learning. 17(1). 102210–102210.
4.
Morgan, Jennifer, et al.. (2023). Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system. Frontiers in Pharmacology. 14. 1274165–1274165. 3 indexed citations
5.
Petry, Natasha, et al.. (2023). Metoprolol and CYP2D6: A Retrospective Cohort Study Evaluating Genotype-Based Outcomes. Journal of Personalized Medicine. 13(3). 416–416. 12 indexed citations
6.
7.
Zawatsky, Carrie L. Blout, Michelle Moore, Natasha Petry, et al.. (2022). Workforce Considerations When Building a Precision Medicine Program. Journal of Personalized Medicine. 12(11). 1929–1929. 10 indexed citations
8.
Petry, Natasha, et al.. (2022). Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships. Frontiers in Genetics. 13. 857120–857120. 1 indexed citations
9.
Petry, Natasha, et al.. (2022). The effect of medication reconciliation on generating an accurate medication list in a pharmacogenomics practice. Annals of Translational Medicine. 10(23). 1259–1259. 8 indexed citations
10.
Luzum, Jasmine A., Natasha Petry, Annette K. Taylor, et al.. (2021). Moving Pharmacogenetics Into Practice: It’s All About the Evidence!. Clinical Pharmacology & Therapeutics. 110(3). 649–661. 40 indexed citations
11.
Petry, Natasha, et al.. (2021). Developing a Standardized Review Process of Pharmacogenomics Resources for Psychotropic Medications. Current pharmacogenomics and personalized medicine (Online). 18(1). 51–55. 1 indexed citations
12.
Gammal, Roseann S., Yee Ming Lee, Natasha Petry, et al.. (2021). Pharmacists Leading the Way to Precision Medicine: Updates to the Core Pharmacist Competencies in Genomics. American Journal of Pharmaceutical Education. 86(4). 8634–8634. 29 indexed citations
13.
Christensen, Kurt D., Carrie L. Blout Zawatsky, Robert C. Green, et al.. (2021). Precision Population Medicine in Primary Care: The Sanford Chip Experience. Frontiers in Genetics. 12. 626845–626845. 33 indexed citations
14.
Kisor, David F., Natasha Petry, & David R. Bright. (2021). Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example. Pharmacogenomics and Personalized Medicine. Volume 14. 569–577. 9 indexed citations
15.
Hicks, J K, et al.. (2020). Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network. SHILAP Revista de lepidopterología. 8 indexed citations
16.
Chen, Aleda M.H., Anastasia L. Armbruster, Devra K. Dang, et al.. (2020). Inclusion of Health Disparities, Cultural Competence, and Health Literacy Content in US and Canadian Pharmacy Curriculums. American Journal of Pharmaceutical Education. 85(1). 8200–8200. 32 indexed citations
17.
Duong, Benjamin Q., Meghan J. Arwood, J. Kevin Hicks, et al.. (2020). <p>Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network</p>. Pharmacogenomics and Personalized Medicine. Volume 13. 217–226. 11 indexed citations
18.
Petry, Natasha, et al.. (2020). Malignant Hyperthermia Susceptibility: Utilization of Genetic Results in an Electronic Medical Record to Increase Safety. Pharmacogenomics. 21(17). 1207–1215. 9 indexed citations
19.
20.
Scott, David, Cynthia A. Naughton, Natasha Petry, & Daniel Friesner. (2019). Assessment of Practice Management Entrustable Professional Activities by Pharmacists in North Dakota. American Journal of Pharmaceutical Education. 83(10). 7486–7486. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jivan Moaddeb Breakdown of academic impact, for papers by Carolyn R. Rohrer Vitek Breakdown of academic impact, for papers by Gillian C. Bell Breakdown of academic impact, for papers by Sieta T. de Vries Breakdown of academic impact, for papers by Kenneth D. Levy Breakdown of academic impact, for papers by Shanna K. O’Connor Breakdown of academic impact, for papers by Diego Chaves‐Gnecco Breakdown of academic impact, for papers by Pipasha Biswas Breakdown of academic impact, for papers by Catherine Chanfreau‐Coffinier Breakdown of academic impact, for papers by Sarah Morris
Rankless by CCL
2026